ELV
Elevance Health, Inc.
NYSE · Healthcare · Medical - Healthcare Plans · US
$422.02
+1.84%Year over year
Reported trailing growth
- Revenue
- +3.6%
- EBITDA
- -11.4%
- EBIT
- -12.0%
- EPS
- -4.2%
- Free cash flow
- +72.9%
- Operating cash flow
- +54.6%
Forward estimates
Based on analyst estimates
- Revenue
- +0.4%
- EBITDA
- +18.0%
- EPS
- +22.8%
Three-year CAGR
- Revenue
- +8.3%
- EBITDA
- -1.6%
- EBIT
- -1.4%
- Net income
- -1.3%
- EPS
- +0.8%
- Free cash flow
- -24.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026